Microtest Laboratories is adding dissolution testing to its analytical testing and stability services. “The addition of dissolution testing is the perfect complement to our portfolio of services,” said Steven Richter, Ph.D., president and scientific founder of Microtest Laboratories. “By offering an even more comprehensive array of assays, we’re increasing the convenience, efficiency, and value that we deliver as a single, preferred provider of contract laboratory services.”

Dissolution is a compendial method used to measure a drug’s rate of release from its dosage form. It is typically used to optimize drug delivery rate during development studies. Dissolution is also for use in routine QC analysis for lot release and variability, stability studies, to compare dosage forms, and to estimate release and absorption rates in humans after an in vitro – in vivo correlation is established.

Microtest’s analytical testing processes follow guidelines from all major standards authorities, including the United States Pharmacopeia (USP), the Japanese and European Pharmacopoeias, the FDA, the International Organization for Standardization (ISO), and the Association for Advancement of Medical Instrumentation (AAMI).